Literature DB >> 11779519

Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome.

William E Hopkins1, Alan D Waggoner.   

Abstract

Why adults with the Eisenmenger syndrome fare so much better than other patients with severe pulmonary hypertension is not known, but may be related to unique hemodynamics found only in these patients and in normal fetuses. We used echocardiography to evaluate ventricular morphology and function in 80 subjects: 45 cyanotic adults and 5 cyanotic adolescents with Eisenmenger syndrome, 10 infants with nonrestrictive ventricular septal defect and left-to-right shunt flow (pre-Eisenmenger phase), and 20 fetuses with structurally normal hearts. Cross-sectional morphology of the hearts was the same in all 4 groups with a flat ventricular septum throughout the cardiac cycle and equal thickness of the right and left ventricular free walls (regression slope 0.98, r = 0.97, p <0.0001). This morphology was the same in patients independent of age, defect type, and ventricular function. Right ventricular fractional area change was slightly inferior to that of the left ventricle but normal in most patients with Eisenmenger syndrome (0.47 +/- 0.14 vs 0.51 +/- 0.13, p <0.01). Overall, there was a highly significant linear relation between right and left ventricular function (r = 0.81, p <0.0001). The hearts of patients with Eisenmenger syndrome are more like normal fetal hearts than normal adult hearts. Because of the unique cardiovascular hemodynamics, regression of right ventricular wall thickness does not occur and is likely the reason that patients with Eisenmenger syndrome fare so much better than other adults with severe pulmonary hypertension.

Entities:  

Mesh:

Year:  2002        PMID: 11779519     DOI: 10.1016/s0002-9149(01)02159-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

Review 1.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 2.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 3.  Right ventricular failure: a novel era of targeted therapy.

Authors:  Dipanjan Banerjee; Francois Haddad; Roham T Zamanian; Jayan Nagendran
Journal:  Curr Heart Fail Rep       Date:  2010-12

4.  Use of Amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension.

Authors:  Alain Fraisse; Philippe Chetaille; Zahid Amin; Francis Rouault; Marc Humbert
Journal:  Pediatr Cardiol       Date:  2006-11-16       Impact factor: 1.655

5.  Right ventricular nitric oxide signaling in an ovine model of congenital heart disease: a preserved fetal phenotype.

Authors:  Rebecca Johnson Kameny; Youping He; Catherine Morris; Christine Sun; Michael Johengen; Wenhui Gong; Gary W Raff; Sanjeev A Datar; Peter E Oishi; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

Review 6.  Treatment of pulmonary arterial hypertension in children.

Authors:  Heiner Latus; Tammo Delhaas; Dietmar Schranz; Christian Apitz
Journal:  Nat Rev Cardiol       Date:  2015-02-03       Impact factor: 32.419

Review 7.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

8.  Nimura lecture: why are you evaluating RV function in patients with pulmonary arterial hypertension?

Authors:  Katsu Takenaka
Journal:  J Echocardiogr       Date:  2018-10-05

9.  The Right Heart in Congenital Heart Disease, Mechanisms and Recent Advances.

Authors:  Julien Guihaire; François Haddad; Olaf Mercier; Daniel J Murphy; Joseph C Wu; Elie Fadel
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

10.  Right ventricular involution: What can we learn from nature's model of compensated hypertrophy?

Authors:  Megan E Bowen; Xiaoqing Liu; Peter M Sundwall; Stavros G Drakos; Dean Y Li; Craig H Selzman; Stephen H McKellar
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-19       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.